Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Droxidopa 400mg	30
Overall Study	STARTED	Droxidopa 600mg	32
Overall Study	STARTED	Placebo	23
Overall Study	Had at Least 1 Post Baseline Visit	Droxidopa 400mg	30
Overall Study	Had at Least 1 Post Baseline Visit	Droxidopa 600mg	31
Overall Study	Had at Least 1 Post Baseline Visit	Placebo	23
Overall Study	Had Visits up to Visit 18	Droxidopa 400mg	28
Overall Study	Had Visits up to Visit 18	Droxidopa 600mg	30
Overall Study	Had Visits up to Visit 18	Placebo	23
Overall Study	COMPLETED	Droxidopa 400mg	26
Overall Study	COMPLETED	Droxidopa 600mg	29
Overall Study	COMPLETED	Placebo	21
Overall Study	NOT COMPLETED	Droxidopa 400mg	4
Overall Study	NOT COMPLETED	Droxidopa 600mg	3
Overall Study	NOT COMPLETED	Placebo	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00657046/flow